These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38728430)

  • 1. The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.
    Cirrincione AM; Poos AM; Ziccheddu B; Kaddoura M; Bärtsch MA; Maclachlan K; Chojnacka M; Diamond B; John L; Reichert P; Huhn S; Blaney P; Gagler D; Rippe K; Zhang Y; Dogan A; Lesokhin AM; Davies F; Goldschmidt H; Fenk R; Weisel KC; Mai EK; Korde N; Morgan GJ; Usmani S; Landgren O; Raab MS; Weinhold N; Maura F
    Blood; 2024 Aug; 144(7):771-783. PubMed ID: 38728430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.
    Chng WJ; Santana-Dávila R; Van Wier SA; Ahmann GJ; Jalal SM; Bergsagel PL; Chesi M; Trendle MC; Jacobus S; Blood E; Oken MM; Henderson K; Kyle RA; Gertz MA; Lacy MQ; Dispenzieri A; Greipp PR; Fonseca R
    Leukemia; 2006 May; 20(5):807-13. PubMed ID: 16511510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis.
    Chang H; Li D; Zhuang L; Nie E; Bouman D; Stewart AK; Chun K
    Leuk Lymphoma; 2004 May; 45(5):965-9. PubMed ID: 15291356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
    Kaufmann H; Ackermann J; Baldia C; Nösslinger T; Wieser R; Seidl S; Sagaster V; Gisslinger H; Jäger U; Pfeilstöcker M; Zielinski C; Drach J
    Leukemia; 2004 Nov; 18(11):1879-82. PubMed ID: 15385925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting karyotypic patterns in non-hyperdiploid multiple myeloma: an overview on the karyotypic evolution.
    Jimenez-Zepeda VH; Braggio E; Fonseca R
    Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):552-8. PubMed ID: 23856591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma.
    Gutiérrez NC; García JL; Hernández JM; Lumbreras E; Castellanos M; Rasillo A; Mateo G; Hernández JM; Pérez S; Orfao A; San Miguel JF
    Blood; 2004 Nov; 104(9):2661-6. PubMed ID: 15238415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biologic implications of recurrent genomic aberrations in myeloma.
    Fonseca R; Blood E; Rue M; Harrington D; Oken MM; Kyle RA; Dewald GW; Van Ness B; Van Wier SA; Henderson KJ; Bailey RJ; Greipp PR
    Blood; 2003 Jun; 101(11):4569-75. PubMed ID: 12576322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.
    Harrison CJ; Mazzullo H; Cheung KL; Gerrard G; Jalali GR; Mehta A; Osier DG; Orchard KH
    Br J Haematol; 2003 Mar; 120(6):944-52. PubMed ID: 12648063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
    Nishida K; Tamura A; Nakazawa N; Ueda Y; Abe T; Matsuda F; Kashima K; Taniwaki M
    Blood; 1997 Jul; 90(2):526-34. PubMed ID: 9226151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal and genetic abnormalities in myeloma.
    Joy Ho P
    Clin Lab Haematol; 2002 Oct; 24(5):259-69. PubMed ID: 12358886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma.
    Trakhtenbrot L; Hardan I; Koren-Michowitz M; Oren S; Yshoev G; Rechavi G; Nagler A; Amariglio N
    Genes Chromosomes Cancer; 2010 Jan; 49(1):17-27. PubMed ID: 19787791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential role for centrosomal deregulation within IgH translocation-positive myeloma.
    Maxwell CA; Pilarski LM
    Med Hypotheses; 2005; 65(5):915-21. PubMed ID: 16023302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.
    Chiecchio L; Dagrada GP; Ibrahim AH; Dachs Cabanas E; Protheroe RK; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
    Haematologica; 2009 Dec; 94(12):1708-13. PubMed ID: 19996118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma.
    Fonseca R; Debes-Marun CS; Picken EB; Dewald GW; Bryant SC; Winkler JM; Blood E; Oken MM; Santana-Dávila R; González-Paz N; Kyle RA; Gertz MA; Dispenzieri A; Lacy MQ; Greipp PR
    Blood; 2003 Oct; 102(7):2562-7. PubMed ID: 12805059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newly diagnosed multiple myeloma patients carrying monoallelic deletion of the whole locus of immunoglobulin heavy chain gene have a better prognosis compared to those with t(4;14) and t(14;16).
    Duek A; Trakhtenbrot L; Amariglio N; Benyamini N; Zilbershats I; Ganzel C; Shevetz O; Leiba R; Rozic G; Nagler A; Leiba M
    Genes Chromosomes Cancer; 2019 Aug; 58(8):516-520. PubMed ID: 30675954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience.
    Carballo-Zarate AA; Medeiros LJ; Fang L; Shah JJ; Weber DM; Thomas SK; Manasanch EE; Hao S; Shen Q; Orlowski RZ; Lin P; Lu X
    Mod Pathol; 2017 Jun; 30(6):843-853. PubMed ID: 28281554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.
    Bergsagel PL; Chesi M; Nardini E; Brents LA; Kirby SL; Kuehl WM
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13931-6. PubMed ID: 8943038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic profiling of multiple myeloma: New insights and modern technologies.
    Hultcrantz M; Yellapantula V; Rustad EH
    Best Pract Res Clin Haematol; 2020 Mar; 33(1):101153. PubMed ID: 32139018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic Abnormalities in Multiple Myeloma Patients at a Tertiary Healthcare Center in India.
    Govindasamy P; Pandurangan P; Tarigopula A; Mani R; R Samuel C
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):235-241. PubMed ID: 30678438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocations.
    Pawlyn C; Melchor L; Murison A; Wardell CP; Brioli A; Boyle EM; Kaiser MF; Walker BA; Begum DB; Dahir NB; Proszek P; Gregory WM; Drayson MT; Jackson GH; Ross FM; Davies FE; Morgan GJ
    Blood; 2015 Jan; 125(5):831-40. PubMed ID: 25428216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.